๐๐๐ซ๐ ๐๐ญ๐ข๐ง๐ ๐๐๐-๐๐ ๐ข๐ง ๐๐๐: ๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐ก๐ฎ๐ซ๐๐ฅ๐๐ฌ, ๐ญ๐ซ๐ข๐๐ฅ ๐๐๐ฌ๐ข๐ ๐ง ๐๐๐๐ข๐๐ข๐๐ง๐๐ข๐๐ฌ, ๐๐ง๐ ๐ญ๐ก๐ ๐๐๐ฎ๐ฌ๐๐ฅ ๐๐ฏ๐ข๐๐๐ง๐๐ ๐ ๐๐ฉ ๐๐จ๐ซ ๐๐๐ฑ๐๐๐๐, Michael A.S. Guth, Drug Discovery Today, Volume 31, Issue 5, 2026, 104752, ISSN 1359-6446, https://doi.org/10.1016/j.drudis.2026.104752. https://www.sciencedirect.com/science/article/pii/S1359644626001571 Highlights โข Over 60 amyotrophic lateral sclerosis (ALS) drug failures since 1995 underscore a persistent trial graveyard. โข CTX1000โs degron fusion selectively clears […]
Archive for the ‘Regulatory Medical Writing’ Category
๐๐๐ซ๐ ๐๐ญ๐ข๐ง๐ ๐๐๐-๐๐ ๐ข๐ง ๐๐๐: ๐๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐ก๐ฎ๐ซ๐๐ฅ๐๐ฌ, ๐ญ๐ซ๐ข๐๐ฅ ๐๐๐ฌ๐ข๐ ๐ง ๐๐๐๐ข๐๐ข๐๐ง๐๐ข๐๐ฌ, ๐๐ง๐ ๐ญ๐ก๐ ๐๐๐ฎ๐ฌ๐๐ฅ ๐๐ฏ๐ข๐๐๐ง๐๐ ๐ ๐๐ฉ ๐๐จ๐ซ ๐๐๐ฑ๐๐๐๐
A microscopic-scale missile system designed to hunt down and destroy rogue cancer cells
Imagine a microscopic-scale missile system designed to hunt down and destroy rogue cancer cells one by one, while leaving healthy tissue completely untouched. That is the revolutionary promise of targeted alpha therapy, a cutting-edge field of medicine using specialized radioactive particles. By attaching these powerful alpha emitters to targeting molecules, doctors can deliver localized radiation […]
Successful integration of Lead-212-targeted alpha therapy into routine clinical practice
Targeted alpha therapy (TAT) represents a transformative shift in precision oncology, offering high linear energy transfer over extremely short cellular paths to eradicate treatment-resistant malignancies. However, translating these powerful radioisotopes from the bench to the bedside introduces complex operational and toxicological bottlenecks. Chief among these is the management of transient daughter radionuclides like Lead-212 and […]
Targeting TDP-43 in ALS: Regulatory Hurdles, Trial Design Deficiencies, and the Causal Evidence Gap for CTx1000
๐๐ฆ๐ฒ๐จ๐ญ๐ซ๐จ๐ฉ๐ก๐ข๐ ๐ฅ๐๐ญ๐๐ซ๐๐ฅ ๐ฌ๐๐ฅ๐๐ซ๐จ๐ฌ๐ข๐ฌ (๐๐๐) ๐ข๐ฌ ๐ ๐๐๐ญ๐๐ฅ ๐ง๐๐ฎ๐ซ๐จ๐๐๐ ๐๐ง๐๐ซ๐๐ญ๐ข๐ฏ๐ ๐๐ข๐ฌ๐๐๐ฌ๐. ๐๐๐๐ข๐๐ง ๐ฌ๐ฎ๐ซ๐ฏ๐ข๐ฏ๐๐ฅ ๐๐ซ๐จ๐ฆ ๐ฌ๐ฒ๐ฆ๐ฉ๐ญ๐จ๐ฆ ๐จ๐ง๐ฌ๐๐ญ ๐ข๐ฌ ๐๐ ๐ญ๐จ ๐๐ ๐ฆ๐จ๐ง๐ญ๐ก๐ฌ, ๐๐ง๐ ๐๐จ๐ซ ๐ฆ๐จ๐ฌ๐ญ ๐ฉ๐๐ญ๐ข๐๐ง๐ญ๐ฌ, ๐ง๐จ ๐๐ฏ๐๐ข๐ฅ๐๐๐ฅ๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐ฒ ๐ฆ๐๐๐ง๐ข๐ง๐ ๐๐ฎ๐ฅ๐ฅ๐ฒ ๐ฌ๐ฅ๐จ๐ฐ๐ฌ ๐ญ๐ก๐๐ญ ๐๐๐๐ฅ๐ข๐ง๐. Since riluzole’s 1995 approval โ which extended median survival by only weeks โ more than 60 compounds have entered clinical trials for ALS, and nearly […]
๐๐ก๐ ๐ข๐ง๐ญ๐ซ๐๐๐๐ฅ๐ฅ๐ฎ๐ฅ๐๐ซ ๐ฅ๐จ๐๐ค๐๐จ๐ฑ: ๐ก๐ฒ๐ฉ๐๐ซ๐ฉ๐ก๐จ๐ฌ๐ฉ๐ก๐จ๐ซ๐ฒ๐ฅ๐๐ญ๐๐ ๐ญ๐๐ฎ: ๐จ๐ง๐ ๐๐ฌ๐ฉ๐๐๐ญ ๐จ๐ ๐ญ๐ก๐ ๐๐ฎ๐๐ฅ ๐๐๐ช๐ฎ๐๐ฌ๐ญ๐ซ๐๐ญ๐ข๐จ๐ง ๐๐ฒ๐ฉ๐จ๐ญ๐ก๐๐ฌ๐ข๐ฌ ๐๐ฒ ๐๐ข๐๐ก๐๐๐ฅ ๐. ๐. ๐๐ฎ๐ญ๐ก
While Aฮฒ patrols the extracellular space, the microtubule-associated protein tau functions within neurons. In its normal state, tau stabilizes micro-tubules, which are crucial for axonal transport and structural integrity. Its pathological transformation into hyperphosphorylated, aggregated NFTs is another diagnostic hallmark of AD and strongly correlates with cognitive decline (Jellinger, 2020). The DSH suggests viewing pathological […]
Has the definition of “positive neuroplasticity”ย and “negative neuroplasticity” evolved over time?
Has the definition of “positive neuroplasticity”ย and “negative neuroplasticity” evolved over time? This publication,ย Vance DE, Roberson AJ, McGuinness TM, Fazeli PL. Howย neuroplasticity and cognitive reserve protect cognitive functioning. Jย Psychosoc Nurs Ment Health Serv. 2010 Apr;48(4):23-30. doi:ย 10.3928/02793695-20100302-01. PMID: 20349891,ย defined โPositive neuroplasticity refers to he physiologicalย ability of the brain to form and strengthen dendritic connections, produceย beneficial morphological changes, […]
Do the Biogen Diranersen Phase 2 (Celia study) results provide counter-evidence to my Dual Sequestration Hypothesis?
DSH vs. Biogen Diranersen Phase 2 (Celia study) โ Compatibility Assessment Bottom line: The Celia results do not constitute counter-evidence to DSH. They’re compatible with its core claim about therapeutic ceilings, but nothing in the trial tests DSH’s actual falsifiable content (nanoplastic nucleation, glymphatic obstruction, NLRP3/pyroptosis, NP-tangle colocalization). Log this as consistent-with, not confirmatory-of. 1. […]
Posted in Neuroplasticity, Pharma and Medical Device, Regulatory Medical Writing 
Comments Off on Do the Biogen Diranersen Phase 2 (Celia study) results provide counter-evidence to my Dual Sequestration Hypothesis?๐๐ก๐ ๐ก๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐๐๐ฅ ๐ ๐ซ๐๐๐ข๐๐ง๐ญ ๐จ๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ’๐ฌ ๐ญ๐ซ๐ข๐ ๐ ๐๐ซ๐ฌ
๐๐ก๐ ๐ก๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐๐๐ฅ ๐ ๐ซ๐๐๐ข๐๐ง๐ญ ๐จ๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ’๐ฌ ๐ญ๐ซ๐ข๐ ๐ ๐๐ซ๐ฌย from industrial contaminants to theย Plasticene A complete understanding of the Dual Sequestration Hypothesisย requires situating the Plasticeneย trigger within a broader historical timeline of escalating environmental neural incursion. AD was not absent before the modern eraโhistorical cases existโbut its incidence has risen dramatically over the past century in a pattern that cannot […]
Posted in Aging Adults, Neuroplasticity, Regulatory Medical Writing Comments Off on ๐๐ก๐ ๐ก๐ข๐ฌ๐ญ๐จ๐ซ๐ข๐๐๐ฅ ๐ ๐ซ๐๐๐ข๐๐ง๐ญ ๐จ๐ ๐๐ฅ๐ณ๐ก๐๐ข๐ฆ๐๐ซ’๐ฌ ๐ญ๐ซ๐ข๐ ๐ ๐๐ซ๐ฌThe Minority View of Aฮฒ in Alzheimer’s Disease is gaining ground on the Established View
We propose the DSH as a unifying framework to resolve these converging crises. This clinicopathological update posits that sporadic AD, particularly in its modern manifestation, could be understood as a disease of maladaptive innate immunity. The DSH suggests reframing Aฮฒ and tau pathologies not as intrinsic pathogens but as visible remnants of overwhelmed, evolutionarily conserved […]
Posted in Aging Adults, Neuroplasticity, Pharma and Medical Device, Regulatory Medical Writing Comments Off on The Minority View of Aฮฒ in Alzheimer’s Disease is gaining ground on the Established ViewThe Dual Sequestration Hypothesis as a Clinicopathological Synthesis
The Dual Sequestration Hypothesis as a Clinicopathological Synthesis We propose theย DSH as a unifying framework to resolve these converging crises. This clinicopathological update posits that sporadic Alzheimer’s disease, particularly in its modern manifestation, could be understood as a disease of maladaptive innate immunity. The DSH suggests reframing Aฮฒ and tau pathologies not as intrinsic pathogens […]
Posted in Aging Adults, Pharma and Medical Device, Regulatory Medical Writing Comments Off on The Dual Sequestration Hypothesis as a Clinicopathological Synthesis